Loading…

Rameda plans to produce new drugs for digestive system, diabetes, nerves, and antibiotics in 2020, and has added production lines including sterile plastic ampoules BFS, raising capacity from 35 million to 144 million ampoules per year.
“The company’s CEO Amr Morsi said that they are currently focusing on launching new products and registering others to increase the market share”zawya.com
Summarized from public sources; check the original articles before acting on it.